Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Jazz Sues Indian Drugmaker Torrent Over Luvox CR Generic

Jazz Pharmaceuticals Inc. sued Torrent Pharmaceuticals Ltd. claiming the Indian drugmaker seeks to sell a generic version of the anti-anxiety medication Luvox CR before a U.S. patent expires.

Jazz is the exclusive licensee for the patent owned by Irish drugmaker Alkermes Plc. Jazz won U.S. approval in February 2008 of Luvox CR for obsessive-compulsive disorder and social anxiety. Torrent advised the companies last month that it would be seeking approval to sell a generic version of the drug’s 100-milligram and 150-milligram capsules, according to the complaint filed in federal court in Wilmington, Delaware.

Luvox, a once-daily treatment, is a selective serotonin reuptake inhibitor, or SSRI, like other drugs used for depression.

OCD affects about 2.2 million American adults, according to the National Institute of Mental Health. About one-third of adults with OCD develop symptoms as children. About 15 million have social anxiety disorder, the Institute said.

Kamesh Venugopal, president of Torrent’s U.S. subsidiary, declined to comment on the complaint.

The case is Alkermes Pharma Ireland Ltd. and Jazz Pharmaceuticals Inc. v. Torrent Pharmaceuticals Ltd., 11-cv-01009, U.S. District Court, District of Delaware (Wilmington).

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.